Documents
Application Sponsors
ANDA 204085 | LANNETT CO INC | |
Marketing Status
Application Products
001 | SOLUTION;ORAL | 100MG/5ML | 0 | OXYCODONE HYDROCHLORIDE | OXYCODONE HYDROCHLORIDE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2014-09-10 | |
REMS; REMS | SUPPL | 4 | AP | 2018-09-18 | |
LABELING; Labeling | SUPPL | 6 | AP | 2020-11-05 | STANDARD |
LABELING; Labeling | SUPPL | 9 | AP | 2020-11-05 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 19 |
SUPPL | 4 | Null | 15 |
SUPPL | 6 | Null | 15 |
SUPPL | 9 | Null | 15 |
CDER Filings
LANNETT CO INC
cder:Array
(
[0] => Array
(
[ApplNo] => 204085
[companyName] => LANNETT CO INC
[docInserts] => ["",""]
[products] => [{"drugName":"OXYCODONE HYDROCHLORIDE","activeIngredients":"OXYCODONE HYDROCHLORIDE","strength":"100MG\/5ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"09\/10\/2014","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2014\\\/204085Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
[supplements] => [{"actionDate":"09\/18\/2018","submission":"SUPPL-4","supplementCategories":"REMS - PROPOSAL - D-N-A","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"09\/25\/2015","submission":"SUPPL-1","supplementCategories":"Labeling-Container\/Carton Labels, Labeling-Medication Guide, Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
[actionDate] => 2018-09-18
)
)